Inflammatory syndrome linked to SARS-CoV-2 can affect adults The CDC says the new adult syndrome closely resembles the previously identified paediatric one.
WHO develops preliminary case definition for inflammatory syndrome in children The COVID-19-associated syndrome seems to be its own unique entity.
Eliminating stigma in practice Stigma and discrimination can be significant barriers to healthcare for marginalised patients – but a new resource aims to help practitioners identify these barriers, and break through them.
GPs and better health outcomes for people in prison The RACGP’s Custodial health in Australia: Tips for providing healthcare to people in prison can help GPs in a unique area of healthcare.
New hepatitis C and diabetes medications available on the PBS Patients with hepatitis C and diabetes will be able to access more affordable treatments from this week, with important medications to be made available through the Pharmaceutical Benefits Scheme.
Recorded penicillin allergy linked to increased risk of ‘superbug’ infections Researchers say more needs to be done to confirm or rule out the presence of true penicillin allergy to reduce the incidence of superbug infections.
How can GPs best deliver bad news? Giving bad news is part of the job for doctors. But does it leave its mark? And how can doctors do it best?
Living with hepatitis C: A patient’s journey, from diagnosis to cure Pamela Wood has lived much of her life as a person with hepatitis C, fighting stigma from the world outside – but also from within herself.
Hepatitis C: Eliminating stigma and boosting treatment Stigma is the greatest barrier preventing people from receiving life-saving treatment for viral hepatitis.
Fighting for the future with hepatitis C treatment in general practice GPs are a major part of a new treatment that can eliminate hepatitis C in Australia, but more patients need to be identified to achieve the best results.